18 F-fluoro-2-deoxy-D-glucose ( 18 F-FDG) positron emission tomography (PET)/computed tomography (CT) has recently been shown to be able to predict a poor outcome after liver transplantation (LT) for patients with hepatocellular carcinoma (HCC). However, there are few reports on the usefulness of PE
Clinical value of18F-fluorodihydroxyphenylalanine positron emission tomography/computed tomography (18F-DOPA PET/CT) for detecting pheochromocytoma
✍ Scribed by Markus Luster; Wolfram Karges; Katrin Zeich; Sandra Pauls; Frederik A. Verburg; Henning Dralle; Gerhard Glatting; Andreas K. Buck; Christoph Solbach; Bernd Neumaier; Sven N. Reske; Felix M. Mottaghy
- Publisher
- Springer
- Year
- 2009
- Tongue
- English
- Weight
- 726 KB
- Volume
- 37
- Category
- Article
- ISSN
- 0340-6997
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
^18^F‐fluoro‐2‐deoxy‐D‐glucose–positron emission tomography (FDG‐PET)/PET‐computed tomography diagnostic studies may play a potential role in the staging and restaging of patients with cervical cancer. Recent work has demonstrated another important aspect of FDG‐PET in predicting the prognosis for p
Objectives/Hypothesis: Using a retrospective approach, the aim of this study was to confirm the previously described value of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography ( 18 F-FDG-PET/CT) in patients with primary extranodal lymphoma of the head and neck region. A